The Value of Routine Intravenous Tranexamic Acid in Total Hip Arthroplasty: A Preliminary Study.

J ChinJ BlackettDavid Christopher KieserC FramptonG Hooper

Published in: Advances in orthopedics (2020)

1 g IV TXA administered on induction did not significantly reduce the need for blood transfusion, postoperative blood loss, functional scores, or the length of stay in patients undergoing THA. This trial is registered with ACTRN12610001065088.

Keyphrases

patients undergoing
total hip arthroplasty
phase iii
study protocol
clinical practice
phase ii
high dose
clinical trial
randomized controlled trial
open label
low dose